• Battaglia G, Yeh SY, De Souza EB (1988). MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.Pharmacol Biochem Behav29: 269–274.

  Article CAS PubMed  Google Scholar 

• Baumann MH, Ayestas MA, Sharpe LG, Lewis DB, Rice KC, Rothman RB (2002). Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate.J Pharmacol Exp Ther301: 1190–1197.

  Article CAS PubMed  Google Scholar 

• Baumann MH, Clark RD, Franken FH, Rutter JJ, Rothman RB (2008). Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.Neuroscience152: 773–784.

  Article CAS PubMed  Google Scholar 

• Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011).In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat.J Pharmacol Exp Ther337: 218–225.

  Article CAS PubMed PubMed Central  Google Scholar 

• Bossong MG, Van Dijk JP, Niesink RJ (2005). Methylone and mCPP, two new drugs of abuse?Addict Biol10: 321–323.

  Article CAS PubMed  Google Scholar 

• Brandt SD, Sumnall HR, Measham F, Cole J (2010). Analyses of second-generation ‘legal highs’ in the UK: initial findings.Drug Test Anal2: 377–382.

  Article CAS PubMed  Google Scholar 

• Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJet al (2010). Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.J Med Chem53: 2204–2214.

  Article CAS PubMed PubMed Central  Google Scholar 

• CDC (2011). Emergency department visits after use of a drug sold as ‘bath salts’---Michigan, November 13, 2010--March 31, 2011.MMWR Morb Mortal Wkly Rep60: 624–627.

  Google Scholar 

• Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987). Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.J Pharmacol Exp Ther241: 338–345.

  CAS PubMed  Google Scholar 

• Cozzi NV, Foley KF (2003). Methcathinone is a substrate for the serotonin uptake transporter.Pharmacol Toxicol93: 219–225.

  Article CAS PubMed  Google Scholar 

• Cozzi NV, Sievert MK, Shulgin AT, Jacob III P, Ruoho AE (1999). Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines.Eur J Pharmacol381: 63–69.

  Article CAS PubMed  Google Scholar 

• Dal Cason TA, Young R, Glennon RA (1997). Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs.Pharmacol Biochem Behav58: 1109–1116.

  Article CAS PubMed  Google Scholar 

• Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza Set al (2004). Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.Mol Pharmacol66: 675–682.

  Article CAS PubMed  Google Scholar 

• de la Torre R, Farre M, Roset PN, Pizarro N, Abanades S, Segura Met al (2004). Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.Ther Drug Monit26: 137–144.

  Article CAS PubMed  Google Scholar 

• Dickson AJ, Vorce SP, Levine B, Past MR (2010). Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin.J Anal Toxicol34: 162–168.

  Article CAS PubMed  Google Scholar 

• EMCDDA (2010).Annual Report on the sSate of Drug Problems in Europe. European Monitoring Centre for Drugs and Drug Addiction: Lisbon.

• Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007). New insights into the mechanism of action of amphetamines.Annu Rev Pharmacol Toxicol47: 681–698.

  Article CAS PubMed  Google Scholar 

• Green AR, O’Shea E, Colado MI (2004). A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.Eur J Pharmacol500: 3–13.

  Article CAS PubMed  Google Scholar 

• Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SCet al (2011). 4-Methylmethcathinone(mephedrone): neuropharmacological effects of a designer stimulant of abuse.J Pharmacol Exp Ther339: 530–536.

  Article CAS PubMed PubMed Central  Google Scholar 

• James D, Adams RD, Spears R, Cooper G, Lupton DJ, Thompson JPet al (2010). Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service.Emerg Med J28: 686–689.

  Article PubMed  Google Scholar 

• Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa Met al (2006). Metabolism of the recently encountered designer drug, methylone, in humans and rats.Xenobiotica36: 709–723.

  Article CAS PubMed  Google Scholar 

• Karila L, Reynaud M (2010). GHB and synthetic cathinones: clinical effects and potential consequences.Drug Test Anal; e-pub ahead of print 2 December 2010.

• Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg Fet al (2011). Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats.Br J Pharmacol; e-pub ahead of print 21 November 2011.

• Lusthof KJ, Oosting R, Maes A, Verschraagen M, Dijkhuizen A, Sprong AG (2011). A case of extreme agitation and death after the use of mephedrone in the Netherlands.Forensic Sci Int206: e93–e95.

  Article PubMed  Google Scholar 

• Malberg JE, Seiden LS (1998). Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.J Neurosci18: 5086–5094.

  Article CAS PubMed PubMed Central  Google Scholar 

• Maskell PD, De Paoli G, Seneviratne C, Pounder DJ (2011). Mephedrone (4-methylmethcathinone)-related deaths.J Anal Toxicol35: 188–191.

  Article CAS PubMed  Google Scholar 

• Meltzer PC, Butler D, Deschamps JR, Madras BK (2006). 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.J Med Chem49: 1420–1432.

  Article CAS PubMed PubMed Central  Google Scholar 

• Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010). Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.Anal Bioanal Chem397: 1225–1233.

  Article CAS PubMed  Google Scholar 

• Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007). The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.Eur J Pharmacol559: 132–137.

  Article CAS PubMed  Google Scholar 

• O’Shea E, Granados R, Esteban B, Colado MI, Green AR (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (‘ecstasy’).Neuropharmacology37: 919–926.

  Article PubMed  Google Scholar 

• Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FIet al (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.Synapse39: 32–41.

  Article CAS PubMed  Google Scholar 

• Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BAet al (2003).In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.J Pharmacol Exp Ther307: 138–145.

  Article CAS PubMed  Google Scholar 

• Shankaran M, Gudelsky GA (1999). A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.Psychopharmacology (Berl)147: 66–72.

  Article CAS  Google Scholar 

• Sitte HH, Freissmuth M (2010). The reverse operation of Na(+)/Cl(−)-coupled neurotransmitter transporters--why amphetamines take two to tango.J Neurochem112: 340–355.

  Article CAS PubMed  Google Scholar 

• Sogawa C, Sogawa N, Ohyama K, Kikura-Hanajiri R, Goda Y, Sora Iet al (2011). Methylone and monoamine transporters: correlation with toxicity.Curr Neuropharmacology9: 58–62.

  Article CAS  Google Scholar 

• Spanos LJ, Yamamoto BK (1989). Acute and subchronic effects of methylenedioxymethamphetamine [(+/−)MDMA] on locomotion and serotonin syndrome behavior in the rat.Pharmacol Biochem Behav32: 835–840.

  Article CAS PubMed  Google Scholar 

• Sparago M, Wlos J, Yuan J, Hatzidimitriou G, Tolliver J, Dal Cason TAet al (1996). Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse.J Pharmacol Exp Ther279: 1043–1052.

  CAS PubMed  Google Scholar 

• Vardakou I, Pistos C, Spiliopoulou C (2011). Drugs for youth via Internet and the example of mephedrone.Toxicol Lett201: 191–195.

  Article CAS PubMed  Google Scholar 

• Willuhn I, Wanat MJ, Clark JJ, Phillips PE (2010). Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse.Curr Top Behav Neurosci3: 29–71.

  Article PubMed PubMed Central  Google Scholar 

• Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F (2011). Mephedrone, new kid for the chop?Addiction106: 154–161.

  Article PubMed  Google Scholar 

• Wise RA (2008). Dopamine and reward: the anhedonia hypothesis 30 years on.Neurotox Res14: 169–183.

  Article PubMed PubMed Central  Google Scholar 

• Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska Het al (2010). Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity.J Med Toxicol6: 327–330.

  Article PubMed PubMed Central  Google Scholar 

• Wood DM, Greene SL, Dargan PI (2011). Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.Emerg Med J28: 280–282.

  Article CAS PubMed  Google Scholar 

• Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola Vet al (2009). Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.J Pharmacol Exp Ther329: 738–746.

  Article CAS PubMed PubMed Central  Google Scholar 

Download references